The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Francis Richard D since 2017.
This trader's CIK number is 1673277.
At the time of last reporting, Francis Richard D was the President and CEO of Teva Pharmaceutical Industries Ltd. (stock ticker symbol TEVA).
Also see all insider trading activities at Teva Pharmaceutical Industries Ltd.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | MTD | 160 | $100,465 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | TEVA | 0 | $0 | 130,621 | $2,158,462 | 279,109 | $0 |
| 2024 | TEVA | 0 | $0 | 105,591 | $1,394,404 | 228,886 | $0 |
1. Mettler Toledo International Inc/ (MTD)
2. Teva Pharmaceutical Industries Ltd (TEVA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-11-17 | MTD | Buy | 160 | 627.91 | 100,465 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-04 | TEVA | Option Ex | 50,223 | .00 | 0 |
| 2025-03-04 | TEVA | Sale | 15,514 | 15.73 | 244,112 |
| 2025-03-05 | TEVA | Sale | 8,259 | 15.91 | 131,425 |
| 2025-03-03 | TEVA | Option Ex | 67,231 | .00 | 0 |
| 2025-03-03 | TEVA | Sale | 24,892 | 16.19 | 402,901 |
| 2025-03-04 | TEVA | Sale | 6,450 | 15.56 | 100,349 |
| 2025-02-18 | TEVA | Sale | 75,506 | 16.95 | 1,279,675 |
| 2025-02-15 | TEVA | Option Ex | 161,655 | .00 | 0 |
| 2024-03-03 | TEVA | Option Ex | 67,231 | .00 | 0 |
| 2024-03-04 | TEVA | Sale | 31,061 | 13.34 | 414,260 |
| 2024-02-15 | TEVA | Option Ex | 161,655 | .00 | 0 |
| 2024-02-15 | TEVA | Sale | 74,530 | 13.15 | 980,144 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Francis Richard D (President and CEO of Teva Pharmaceutical Industries Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.